• English
    • Deutsch
  • English 
    • English
    • Deutsch
  • Login
View Item 
  •   Home
  • Universität Ulm / Medizin
  • Publikationsnachweise
  • View Item
  •   Home
  • Universität Ulm / Medizin
  • Publikationsnachweise
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33

Erstveröffentlichung
2012
Authors
Azoitei, Ninel
Hoffmann, Christopher M.
Ellegast, Jana M.
Ball, Claudia R.
Obermayer, Kerstin
et al.
Wissenschaftlicher Artikel


Published in
Journal of Experimental Medicine ; 209 (2012), 4. - S. 697-711. - ISSN 0022-1007. - eISSN 1540-9538
Link to publication
https://dx.doi.org/10.1084/jem.20111910
Faculties
Fakultät für Ingenieurwissenschaften, Informatik und Psychologie
Institutions
UKU. Klinik für Innere Medizin III
UKU. Klinik für Urologie und Kinderurologie
Institut für Neuroinformatik
Subject headings
[Free subject headings]: synthetic lethal interaction | small-molecule inhibitors | breast-cancer | ras oncogenes | tanespimycin 17-aag | therapeutic target | mek inhibitors | lung cancers | cells | growth
[DDC subject group]: DDC 610 / Medicine & health

Metadata
Show full item record

Policy | kiz service OPARU | Contact Us
Impressum | Privacy statement
 

 

Advanced Search

Browse

All of OPARUCommunities & CollectionsPersonsInstitutionsPublication typesUlm SerialsDewey Decimal ClassesEU projects UlmDFG projects UlmOther projects Ulm

My Account

LoginRegister

Statistics

View Usage Statistics

Policy | kiz service OPARU | Contact Us
Impressum | Privacy statement